Alignment Healthcare (NASDAQ:ALHC) Upgraded at Zacks Research

Key Points

• Alignment Healthcare (ALHC) has been upgraded to a "strong-buy" rating by Zacks Research, reflecting positive sentiment among analysts.
• The company reported a 49% year-over-year revenue increase of $1.02 billion and earnings per share of $0.07, exceeding estimates.
• Insider trading activity has seen significant share sales, with insiders selling over 7.3 million shares valued at approximately $118 million in the last ninety days.

Alignment Healthcare (NASDAQ:ALHC - Get Free Report) was upgraded by research analysts at Zacks Research from a "hold" rating to a "strong-buy" rating in a research note issued to investors on Monday,Zacks.com reports.

ALHC has been the topic of several other research reports. Stephens raised Alignment Healthcare to a "strong-buy" rating in a research note on Monday, June 2nd. Barclays upgraded shares of Alignment Healthcare from an "underweight" rating to an "equal weight" rating and increased their price objective for the company from $9.00 to $13.00 in a report on Thursday, July 31st. KeyCorp upgraded shares of Alignment Healthcare from a "sector weight" rating to an "overweight" rating and set a $21.00 price objective for the company in a report on Monday, August 25th. Finally, Wall Street Zen downgraded Alignment Healthcare from a "buy" rating to a "hold" rating in a research note on Sunday, August 10th. Two investment analysts have rated the stock with a Strong Buy rating, six have assigned a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus target price of $18.83.

Alignment Healthcare Price Performance

Shares of ALHC opened at $17.45 on Monday. The firm has a market cap of $3.46 billion, a price-to-earnings ratio of -62.32 and a beta of 1.17. The stock has a 50 day moving average of $15.32 and a 200-day moving average of $15.66. The company has a current ratio of 1.66, a quick ratio of 1.66 and a debt-to-equity ratio of 2.29. Alignment Healthcare has a 52 week low of $9.15 and a 52 week high of $21.06.

Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last announced its quarterly earnings results on Wednesday, July 30th. The company reported $0.07 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.07) by $0.14. The business had revenue of $1.02 billion for the quarter, compared to the consensus estimate of $960.25 million. Alignment Healthcare had a negative return on equity of 43.68% and a negative net margin of 1.53%.The business's revenue was up 49.0% on a year-over-year basis. During the same quarter last year, the business posted ($0.13) EPS. Alignment Healthcare has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. As a group, analysts forecast that Alignment Healthcare will post -0.69 EPS for the current year.

Insider Activity at Alignment Healthcare

In other news, insider Robert L. Scavo sold 29,535 shares of the business's stock in a transaction on Wednesday, September 10th. The stock was sold at an average price of $16.41, for a total transaction of $484,669.35. Following the sale, the insider directly owned 572,555 shares of the company's stock, valued at $9,395,627.55. The trade was a 4.91% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Christopher J. Joyce sold 30,939 shares of the business's stock in a transaction on Wednesday, September 10th. The stock was sold at an average price of $16.41, for a total value of $507,708.99. Following the sale, the insider directly owned 343,592 shares in the company, valued at $5,638,344.72. This trade represents a 8.26% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 7,388,173 shares of company stock valued at $118,068,256 over the last ninety days. Company insiders own 6.60% of the company's stock.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the business. MCF Advisors LLC raised its position in Alignment Healthcare by 87.6% during the first quarter. MCF Advisors LLC now owns 2,165 shares of the company's stock valued at $40,000 after buying an additional 1,011 shares during the period. Skandinaviska Enskilda Banken AB publ acquired a new stake in shares of Alignment Healthcare during the 1st quarter valued at $42,000. SBI Securities Co. Ltd. boosted its stake in shares of Alignment Healthcare by 4,868.9% during the 2nd quarter. SBI Securities Co. Ltd. now owns 3,031 shares of the company's stock valued at $42,000 after buying an additional 2,970 shares during the period. KBC Group NV acquired a new stake in shares of Alignment Healthcare during the 2nd quarter valued at $44,000. Finally, Signaturefd LLC boosted its stake in shares of Alignment Healthcare by 142.6% during the 2nd quarter. Signaturefd LLC now owns 3,768 shares of the company's stock valued at $53,000 after buying an additional 2,215 shares during the period. 86.19% of the stock is owned by institutional investors and hedge funds.

About Alignment Healthcare

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.